Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
Applied Molecular Transport Reports Third Quarter 2023 Financial Results
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
What Makes Applied Molecular Transport Inc. (AMTI) a New Buy Stock
Is Applied Molecular Transport (AMTI) Stock Outpacing Its Medical Peers This Year?
Applied Molecular Transport to Present at Upcoming November Investor Conferences
Zephyr AI Announces Additions to the Board of Directors
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Applied Molecular Transport Inc. with Losses of $100,000 to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Applied Molecular Transport Inc. with Losses of $100,000 to Contact the Firm
Applied Molecular Transport to Report Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
VMware Advances Its Anywhere Workspace Platform To Enable Intelligent, Proactive Security for All Employee Devices
Applied Molecular Cuts Its Workforce By 40%, Pauses Early-Stage Research Programs
Applied Molecular Transport to Present at BofA Securities 2022 Healthcare Conference
Applied Molecular Transport to Report Top-line Phase 2 Results from FILLMORE Trial of Oral AMT-101 in Patients with Chronic Pouchitis
Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference
Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021
Applied Molecular Transport Announces Upcoming Investor Events in September and October
Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
AMTI Stock Price Increases Over 20% Pre-Market: Why It Happened
Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress
Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference
VMware Empowers Today’s Anywhere Workforce
Applied Molecular Transport Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Applied Molecular Transport Stock Price Increased 44.44%: Why It Happened
Applied Molecular Transport Stock Price Increased Over 25% Intraday: Why It Happened
Applied Molecular Transport Announces Pricing of Public Offering of Common Stock
Applied Molecular Transport Announces Proposed Public Offering of Common Stock
Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
3 Biotech Stocks That Have Already Rocketed Higher in 2021
Applied Molecular Transport to Present at Oppenheimer 31st Annual Healthcare Conference
Applied Molecular Transport Expands Clinical Pipeline and Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126
Stocks To Watch: Fireworks For Nikola, Tesla And Micron
CBL Properties Announces Tax Reporting Information for 2017 Common and Preferred Share Dividends
American Tower Corporation Announces Tax Reporting Information for 2017 Distributions
GGP Announces Tax Reporting Information for 2017 Distributions
CBL & Associates Properties Announces Tax Reporting Information for 2016 Common and Preferred Share Distributions
American Tower Corporation Announces Tax Reporting Information for 2016 Distributions